Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Medical Costs in the Year Following Kidney Transplantation: Relationships with Renal Function and Graft Failure
M. Cooper¹, M. A. Schnitzler², C. Nilubol¹, W. Wang³, X. Zhu³, J. Wu³, R. J. Nordyke⁴
¹MedStar Georgetown Transplant Institute, Washington, DC, ²Saint Louis University, St. Louis, MO, ³Genesis Research, Hoboken, NJ, ⁴Angion Biomedica, San Francisco, CA
*Purpose: We describe relationships between total medical costs in the first year following kidney transplant with overall renal function as measured by: 1) estimated glomerular…
2021 American Transplant Congress
PDSA Model to Improve Pneumococcal Vaccine Adherence Among Kidney Transplant Candidates
J. M. Ramakrishna, L. Brumble, C. R. Libertin
Division of Infectious Diseases, Mayo Clinic, Florida, Jacksonville, FL
*Purpose: Streptococcus pneumoniae infections occur in solid organ transplant patients at a rate of 146 per 100,000 persons per year versus 11.5 per 100,000 persons…
2021 American Transplant Congress
Infectious Complications and Malignancy After Kidney Transplantation in the Elderly Population
L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Le, H. Yaffe, M. Kinkhabwala, J. Rocca, E. Akalin
Montefiore Medical Center, New York, NY
*Purpose: All patients, regardless of age, may benefit from renal transplantation due to improved quality of life and decreased mortality. However, elderly patients are at…
2021 American Transplant Congress
Conversion from Tacrolimus to Envarsus in Rapid Metabolizers for Prevention of BK Infection
G. Towns, G. Agarwal, C. Kew
Transplant Nephrology, UAB, Birmingham, AL
*Purpose: The incidence of BK virus infection is high among rapid metabolizers (RM) in kidney transplant (KT) patients. RM can be identified using validated and…
2021 American Transplant Congress
Outcomes in Highly Sensitized Kidney Transplant Recipients Receiving DCD Organs
A. Diamond¹, L. Rodrigues², A. Di Carlo³, S. Karhadkar³
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Temple University, Philadelphia, PA, ³Surgery, Temple University Hospital, Philadelphia, PA
*Purpose: Highly sensitized (HS) patients experience longer wait times for kidney transplantation despite prioritization by the Kidney Allocation System. Kidney transplants performed from donors defined…
2021 American Transplant Congress
Use of Hepatitis B N.A.T. Positive Kidneys in Hepatitis B Immune Recipients
E. Stephenson¹, B. Nangunuri², T. McCune³
¹Nephrology and Critical Care, Eastern Virginia Medical School, Norfolk, VA, ²Eastern Virginia Medical School, Norfolk, VA, ³Nephrology, Eastern Virginia Medical School, Norfolk, VA
*Purpose: There is an increasing demand for kidney donations as roughly 4000 people die on the waitlist each year while the number of kidneys being…
2021 American Transplant Congress
Information-Seeking Behavior During Covid-19: Opportunities for Communication and Care Transition Improvements
S. H. Advani¹, S. M. Advani², Y. A. Iraheta³, A. Murillo⁴, H. A. Gritsch³, A. D. Waterman³
¹Terasaki Institute, Bethesda, MD, ²National Human Genome Research Institute, Bethesda, MD, ³UCLA, Los Angeles, CA, ⁴Terasaki Institute, Los Angeles, CA
*Purpose: To learn more about how at-risk dialysis and transplant patients sought health information during COVID-19 and what was most helpful, we conducted a mixed-methods…
2021 American Transplant Congress
Iguratimod Reduce Panel Reactive Antibody in High Mismatched Renal Transplant Recipients: A Retrospective Propensity Score-Matched Study
D. Feng, Z. Wang, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu
The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
*Purpose: To evaluate the clinical efficacy and safety of iguratimod (IGU) for reducing panel reactive antibody (PRA) in high mismatched renal transplant recipients.*Methods: Eligible recipients…
2021 American Transplant Congress
Kidney Transplant Outcomes Stratified by Age with a Calcineurin and Steroid Free Regimen
R. Scalzo¹, M. Harris¹, J. Morris², J. Byrns¹
¹Pharmacy, Duke University Hospital, Durham, NC, ²Nephrology, Duke University Hospital, Durham, NC
*Purpose: To evaluate the impact of an alemtuzumab, belatacept, and sirolimus based regimen on renal function stratified by age in kidney transplant (KT) patients.*Methods: This…
2021 American Transplant Congress
The Impact of Donor Age and Donor-Recipient Age Difference on Living Donor Kidney Transplantation
T. Hiramitsu¹, T. Tomosugi², K. Futamura², M. Okada², N. Goto², T. Ichimori², S. Narumi², Y. Watarai²
¹Nagoya Daini Red Cross Hospital, Myokencho Showaku, Japan, ²Nagoya Daini Red Cross Hospital, Nagoya, Japan
*Purpose: The impact of donor age and donor-recipient age difference on living donor kidney transplantation have not been investigated simultaneously.*Methods: A total 805 adult living…